Company Expects to Submit Trial Results to FDA in Fourth Quarter of 2017 Redwood City, CA – October 18, 2016 - Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for treatment of benign uterine conditions, today announced the completion of
Uterine Fibroid Clinical Study at Mercy Hospital, St. Louis
Fox2 News Dr. David Levine is a gynecologist with Mercy Hospital, St. Louis who discusses traditional treatments for uterine fibroids and the SONATA Study offering the latest technology. Mercy Hospital is the only clinical study site in the state amongst 22 other US sites. Read
Doctors Test New Device for Uterine Fibroids
Philly.com Dr. Nicole Morin, Dr. Minda Green, Dr. Dipak Delvadia, and Marisol Burgos watch the computer screen during performance of a new procedure using ultrasound and radio frequency for a trans-cervical uterine fibroid ablation at Hahnemann Hospital in Philadelphia on Monday, April 25, 2016.
Gynesonics Names Jiayu Chen, PhD, Vice President, Engineering and Advanced Technologies
Redwood City, CA – May 5, 2016 - Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that medical device executive Jiayu Chen, Ph.D., has been named Vice President of Engineering and
University of Maryland Tests Nonsurgical Method of Treating Common Fibroids
Baltimore Sun Dr. Vadim Morozov, assistant professor of obstetrics and gynecology at the University of Maryland Medical Center, is testing the Sonata System, which is used to image and treat fibroids without surgery. Read more>>
Gynesonics Names Taraneh G. Farazi Vice President, Clinical Affairs
Accomplished Clinical Affairs Executive to Lead Clinical Research Initiatives and Programs Redwood City, CA – February 25, 2016 - Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that veteran
Gynesonics Completes $46 Million Equity Financing
Novit Ventures LP Participates in Latest Round Redwood City, CA - November 17, 2015 - Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced $2.9 million of additional equity financing, increasing the
Gynesonics Technology Featured in Five Presentations at 2015 American Association of Gynecologic Laparoscopists Global Congress
Presentation on Early Clinical Response to Sonata™ System Selected as Best Abstract In New Instrumentation/Technology Category Redwood City, CA—November 12, 2015 – Gynesonics, Inc., a women’s health technology company focused on the development and commercialization of breakthrough products